Cargando…

The Ocular Status of Cystinosis Patients Receiving a Hospital Pharmacy-Made Preparation of Cysteamine Eye Drops: A Case Series

INTRODUCTION: Infantile nephropathic cystinosis (INC) is an autosomal recessive lysosomal disorder in which patients develop deposits of cystine crystals in their kidneys and corneas from a young age. METHODS: We conducted a retrospective analysis of children with INC seen by ophthalmologists at the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Biswas, Susmito, Sornalingam, Krishanthy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2018
Materias:	Case Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393247/ https://www.ncbi.nlm.nih.gov/pubmed/30519924 http://dx.doi.org/10.1007/s40123-018-0156-4

Ejemplares similares

Ophthalmic Outcome in a Belgian Cohort of Cystinosis Patients Treated with a Compounded Preparation of Cysteamine Eye Drops: Retrospective Analysis
por: Peeters, Freya, et al.
Publicado: (2019)

Importance of adherence to topical cysteamine in infantile ocular cystinosis: An illustrative case
por: Bayram-Suverza, Mauricio, et al.
Publicado: (2022)

Latest Clinical Approaches in the Ocular Management of Cystinosis: A Review of Current Practice and Opinion from the Ophthalmology Cystinosis Forum
por: Biswas, Susmito, et al.
Publicado: (2018)

Cysteamine hydrochloride eye drop solution for the treatment of corneal cystine crystal deposits in patients with cystinosis: an evidence-based review
por: Makuloluwa, Achini K, et al.
Publicado: (2018)

Enteric-Coated Cysteamine Bitartrate in Cystinosis Patients
por: Klank, Sabrina, et al.
Publicado: (2023)

Population pharmacokinetics and pharmacodynamics of cysteamine in nephropathic cystinosis patients
por: Bouazza, Naïm, et al.
Publicado: (2011)

Effects of long-term cysteamine treatment in patients with cystinosis
por: Ariceta, Gema, et al.
Publicado: (2017)

Recent Research in Ocular Cystinosis: Drug Delivery Systems, Cysteamine Detection Methods and Future Perspectives
por: Castro-Balado, Ana, et al.
Publicado: (2020)

Cysteamine–bicalutamide combination therapy corrects proximal tubule phenotype in cystinosis
por: Jamalpoor, Amer, et al.
Publicado: (2021)

Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence
por: Castro-Balado, Ana, et al.
Publicado: (2022)

Limitations and Challenges in the Stability of Cysteamine Eye Drop Compounded Formulations
por: Martín-Sabroso, Cristina, et al.
Publicado: (2021)

Cystinosis: Therapy adherence and metabolic monitoring in patients treated with immediate-release cysteamine
por: Linden, Simone, et al.
Publicado: (2020)

Long-term clinical benefits of delayed-release cysteamine bitartrate capsules in patients with nephropathic cystinosis (response to “A comparison of immediate release and delayed release cysteamine in 17 patients with nephropathic cystinosis”)
por: Langman, Craig B.
Publicado: (2023)

A comparison of immediate release and delayed release cysteamine in 17 patients with nephropathic cystinosis
por: van Stein, Christina, et al.
Publicado: (2021)

Long-term follow-up of cystinosis patients treated with 0.55% cysteamine hydrochloride
por: Liang, Hong, et al.
Publicado: (2021)

Analysis of tear film in cystinosis patients treated with topical viscous cysteamine hydrochloride (Cystadrops(®))
por: Sergio, Petroni, et al.
Publicado: (2022)

A new proof of evidence of cysteamine quantification for therapeutic drug monitoring in patients with cystinosis
por: Franzin, Martina, et al.
Publicado: (2022)

Cysteamine (Cystagon®) adherence in patients with cystinosis in Spain: successful in children and a challenge in adolescents and adults
por: Ariceta, Gema, et al.
Publicado: (2015)

Response to Cysteamine in Osteoclasts Obtained from Patients with Nephropathic Cystinosis: A Genotype/Phenotype Correlation
por: Quinaux, Thomas, et al.
Publicado: (2021)

Plasma rich in growth factors eye drops to treat secondary ocular surface disorders in patients with glaucoma
por: Sánchez-Avila, Ronald M, et al.
Publicado: (2018)

Ocular cystinosis: Rarity redefined
por: Naik, Mayuresh P, et al.
Publicado: (2019)

Genistein improves renal disease in a mouse model of nephropathic cystinosis: a comparison study with cysteamine
por: De Leo, Ester, et al.
Publicado: (2022)

Impact of compliance to oral cysteamine treatment on the costs of Kidney failure in patients with nephropathic cystinosis in the United Kingdom
por: Lashilola, Seun, et al.
Publicado: (2023)

Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems, Part II: Long-Term Stability and Clinical Ocular Biopermanence
por: Castro-Balado, Ana, et al.
Publicado: (2023)

In vivo confocal microscopy and anterior segment optical coherence tomography follow-up of cysteamine treatment in corneal cystinosis
por: Ozdemir, Huseyin Baran, et al.
Publicado: (2019)

A novel sustained‐release cysteamine bitartrate formulation for the treatment of cystinosis: Pharmacokinetics and safety in healthy male volunteers
por: Berends, Cécile L., et al.
Publicado: (2021)

Quality of Life is Improved and Kidney Function Preserved in Patients with Nephropathic Cystinosis Treated for 2 Years with Delayed-Release Cysteamine Bitartrate
por: Langman, Craig B., et al.
Publicado: (2014)

The effects of transitioning from immediate release to extended release cysteamine therapy in Norwegian patients with nephropathic cystinosis: a retrospective study
por: Bjerre, Anna, et al.
Publicado: (2023)

A Phase 1 Pharmacokinetic Study of Cysteamine Bitartrate Delayed-Release Capsules Following Oral Administration with Orange Juice, Water, or Omeprazole in Cystinosis
por: Armas, Danielle, et al.
Publicado: (2018)

Human and animal fertility studies in cystinosis reveal signs of obstructive azoospermia, an altered blood‐testis barrier and a subtherapeutic effect of cysteamine in testis
por: Reda, Ahmed, et al.
Publicado: (2021)

Neuroretinitis in ocular bartonellosis: a case series
por: Raihan, Abdul-Rahim, et al.
Publicado: (2014)

Ocular adnexal sporotrichosis: A case series
por: Ramírez-Oliveros, Joaquín Felipe, et al.
Publicado: (2021)

Asymmetrical Ocular Manifestations of Nephropathic Cystinosis; A Case Report
por: Helmi, Hala A., et al.
Publicado: (2019)

Molecular characterization of CTNS mutations in Tunisian patients with ocular cystinosis
por: Chkioua, Latifa, et al.
Publicado: (2022)

Segmented swept source optical coherence tomography angiography assessment of the perifoveal vasculature in patients with X-linked juvenile retinoschisis: a serial case report
por: Stringa, Francesco, et al.
Publicado: (2017)

How to prepare chlorhexidine eye drops
por: Mohamed-Ahmed, Abeer H A, et al.
Publicado: (2023)

Systane(®) lubricant eye drops in the management of ocular dryness
por: Benelli, Umberto
Publicado: (2011)

Presumptive ocular tuberculosis: A case series of rare cases
por: Singh, Arti, et al.
Publicado: (2023)

Use of Ozone-Based Eye Drops: A Series of Cases in Veterinary and Human Spontaneous Ocular Pathologies
por: Spadea, Leopoldo, et al.
Publicado: (2018)

Fertility in Cystinosis
por: Reda, Ahmed, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_67qs2r4iiq12vvk92bga6fgonq